logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > MEPREDNISONE CAS 1247-42-3

MEPREDNISONE CAS 1247-42-3

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1247-42-3

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:

Meprednisone API powder

,

Meprednisone CAS 1247-42-3

,

Active Pharmaceutical Ingredient Meprednisone

CAS NO::
1247-42-3
Appearance::
White Solid
Molecular Formula::
C22H28O5
Molecular Weight::
372.45500
EINECS NO::
214-996-1
MDL NO::
MFCD00083662
CAS NO::
1247-42-3
Appearance::
White Solid
Molecular Formula::
C22H28O5
Molecular Weight::
372.45500
EINECS NO::
214-996-1
MDL NO::
MFCD00083662
MEPREDNISONE CAS 1247-42-3

Product Description:

Product Name: MEPREDNISONE CAS NO: 1247-42-3

 

 

Synonyms:

bitanisone;

deltisonab;

betapred;

 

 

Chemical & Physical Properties:

Appearance: White solid

Assay :≥99.0%

Density: 1.28g/cm3

Boiling Point: 574.4℃ at 760mmHg

Melting Point: 204-206℃

Flash Point: 315.2℃

Refractive Index: 1.595

Vapor Pressure: 1.39E-15mmHg at 25℃

 

 

Safety Information:

HS Code: 2937210000

 

 

Meprednisone is a glucocorticoid and a methylated derivative of prednisone.Target: Glucocorticoid ReceptorMeprednisone is a glucocorticoid and a methylated derivative of prednisone. The methylprednisone to MPL area under the curve ratio decreased from 0.19 +/- 0.04 in control to 0.14 +/- 0.03 in ketoconazole-treated rats (P less than .05) due to altered interconversion between these stero-ids. An improved pharmacokinetic/dynamic receptor/gene-mediated model characterized the stero-id receptor binding and induction of tyrosine aminotransferase activity after i.v. MPL sodium succinate (10 mg/kg). In contrast to previous in vitro studies, ketoconazole at maximally tolerated doses failed to antagonize the stero-id receptor-mediated activity of MPL.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.